Skip to main content

See how Novartis is responding to Coronavirus (COVID-19)

Read more

This site is intended for UK healthcare professionals only. If you are a member of the public, please click here

Home
  • Home
  • Medicines
    • Cardio-Metabolic
      • ENTRESTO® (sacubitril/valsartan)
    • Dermatology
      • COSENTYX® (secukinumab)
      • XOLAIR® (omalizumab)
    • Haematology
      • EXJADE® ▼ (deferasirox)
      • JAKAVI® (ruxolitinib)
      • REVOLADE® (eltrombopag olamine)
      • RYDAPT® ▼ (midostaurin)
      • TASIGNA® (nilotinib)
    • Neuroscience
      • EXTAVIA® (interferon beta-1b)
      • GILENYA® ▼ (fingolimod)
      • MAYZENT® ▼ (siponimod)
    • Oncology
      • KISQALI® ▼ (ribociclib)
      • PIQRAY® ▼ (alpelisib)
      • TAFINLAR® (dabrafenib) + MEKINIST® (trametinib)
    • Ophthalmology
      • ▼ BEOVU® (brolucizumab)
      • LUCENTIS® (ranibizumab)
      • LUXTURNA®▼ (voretigene neparvovec)
    • Rare diseases
      • ILARIS® (canakinumab)
    • Respiratory and Inflammation
      • XOLAIR® (omalizumab)
      • ATECTURA® BREEZHALER® (indacaterol acetate/mometasone furoate inhalation powder)
      • ENERZAIR® BREEZHALER® (indacaterol acetate/glycopyrronium bromide/mometasone furoate inhalation powder)
    • Rheumatology
      • COSENTYX® (secukinumab)
  • Therapy Areas
    • Cardio-Metabolic
    • Dermatology
    • Haematology
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Rare diseases
    • Respiratory and Inflammation
  • Events and Webinars
    • Cardio-Metabolic
      • Product events and webinars
    • Dermatology
      • Product events and webinars
    • Haematology
      • Product events and webinars
    • Neuroscience
    • Oncology
      • Product events and webinars
    • Ophthalmology
      • Product events and webinars
      • Therapy area events and webinars
    • Rare diseases
    • Respiratory and Inflammation
      • Product events and webinars
    • Rheumatology
      • Product events and webinars
    • Programmes
  • Resources and Training
    • Cardio-Metabolic
      • Product resources and training
      • Therapy area resources and training
    • Dermatology
      • Product resources and training
      • Therapy area resources and training
    • Haematology
      • Product resources and training
      • Therapy area resources and training
    • Neuroscience
      • Product resources and training
      • Therapy area resources and training
    • Oncology
      • Product resources and training
      • Therapy area resources and training
    • Ophthalmology
      • Product resources and training
    • Rare diseases
      • Product resources and training
    • Respiratory and Inflammation
      • Product resources and training
      • Therapy area resources and training
    • Rheumatology
      • Product resources and training

Popular Search

  • sickle cell
  • quickly cells
  • sickle
  • quick
  • quickly

Recent News

Entresto cardiac remodelling video
Haematology Masterclass 2021
Resources for nurses: the Heart To Heart series
Search
×

Ask Speakers

You do not have an account yet? Register here.

Register with pin code
You have received a personal PIN code? Enter it here to register with Healthy Together.

If you have been supplied with a PIN Code, you may enter it here.

Register with your email address

Register with E-mail
×

Medical Information Request

User login

Login with your personal account

  • Forgot Password?
  • Contact Us
  • Privacy Notice
  • Terms of Use
  • Accessibility
Site directory
Cookie Settings
©2021 Novartis Pharmaceuticals UK Limited. All rights reserved.
This site is intended for a UK healthcare professional audience only.

Novartis Pharmaceuticals UK Limited is a limited liability company registered in England and Wales under number 119006.
Registered office: The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ

UK | February 2021 | 104892